M. Shimoda

748 total citations
47 papers, 628 citations indexed

About

M. Shimoda is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, M. Shimoda has authored 47 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 16 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in M. Shimoda's work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Drug Transport and Resistance Mechanisms (16 papers) and Pharmacogenetics and Drug Metabolism (11 papers). M. Shimoda is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (23 papers), Drug Transport and Resistance Mechanisms (16 papers) and Pharmacogenetics and Drug Metabolism (11 papers). M. Shimoda collaborates with scholars based in Japan, Netherlands and Egypt. M. Shimoda's co-authors include T. B. Vree, A.M. Abd El‐Aty, A. Goudah, Y. A. Hekster, Masanori Kuroha, Ho‐Chul Shin, Ruben van den Bosch, Deok‐Soo Son, R Ohno and Kenichi Sasaki and has published in prestigious journals such as American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Drug Metabolism and Disposition and Journal of Veterinary Pharmacology and Therapeutics.

In The Last Decade

M. Shimoda

46 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Shimoda Japan 16 291 168 145 93 74 47 628
Edward J. Mroszczak United States 13 360 1.2× 101 0.6× 136 0.9× 118 1.3× 60 0.8× 26 794
J. J. Aramayona Spain 17 299 1.0× 116 0.7× 41 0.3× 147 1.6× 46 0.6× 36 657
Steven R. Cox United States 15 196 0.7× 134 0.8× 154 1.1× 66 0.7× 16 0.2× 35 714
Eiichi KOKUE Japan 12 86 0.3× 106 0.6× 118 0.8× 74 0.8× 27 0.4× 54 454
Michael Deters Germany 18 184 0.6× 133 0.8× 142 1.0× 154 1.7× 25 0.3× 42 865
Roger D. Toothaker United States 14 246 0.8× 67 0.4× 94 0.6× 102 1.1× 29 0.4× 26 604
Tsuyoshi Ooie Japan 14 320 1.1× 466 2.8× 399 2.8× 205 2.2× 40 0.5× 19 990
Terry J. Gilbertson United States 16 279 1.0× 70 0.4× 27 0.2× 163 1.8× 39 0.5× 36 773
Kimiko Tsutsumi Japan 14 182 0.6× 193 1.1× 180 1.2× 118 1.3× 23 0.3× 40 837
Vijay O. Bhargava United States 15 155 0.5× 100 0.6× 96 0.7× 44 0.5× 23 0.3× 35 480

Countries citing papers authored by M. Shimoda

Since Specialization
Citations

This map shows the geographic impact of M. Shimoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Shimoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Shimoda more than expected).

Fields of papers citing papers by M. Shimoda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Shimoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Shimoda. The network helps show where M. Shimoda may publish in the future.

Co-authorship network of co-authors of M. Shimoda

This figure shows the co-authorship network connecting the top 25 collaborators of M. Shimoda. A scholar is included among the top collaborators of M. Shimoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Shimoda. M. Shimoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Aty, A.M. Abd, et al.. (2007). Lack of inhibitory effects of several fluoroquinolones on cytochrome P‐450 3A activities at clinical dosage in dogs. Journal of Veterinary Pharmacology and Therapeutics. 30(1). 37–42. 12 indexed citations
2.
Sanda, Srinath, et al.. (2007). Characterization of cytochrome P450‐mediated drug metabolism in cats. Journal of Veterinary Pharmacology and Therapeutics. 30(5). 422–428. 39 indexed citations
3.
El‐Aty, A.M. Abd, et al.. (2005). Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P‐450 1A activities in dogs. Journal of Veterinary Pharmacology and Therapeutics. 28(6). 553–557. 28 indexed citations
4.
Kuroha, Masanori, et al.. (2004). Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs. Journal of Veterinary Pharmacology and Therapeutics. 27(5). 355–359. 16 indexed citations
5.
Horii, Yoshihiro, et al.. (2004). Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver. Journal of Veterinary Pharmacology and Therapeutics. 27(2). 65–69. 26 indexed citations
6.
Shimoda, M., et al.. (2000). Disease‐induced alterations in plasma drug‐binding proteins and their influence on drug binding percentages in dogs. Veterinary Quarterly. 22(1). 43–49. 11 indexed citations
7.
Shimoda, M., et al.. (2000). The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits. Journal of Veterinary Pharmacology and Therapeutics. 23(3). 153–158. 18 indexed citations
8.
Shimoda, M., et al.. (1997). Deacetylation as a determinant of sulphonamide pharmacokinetics in pigs. Veterinary Quarterly. 19(4). 186–191. 6 indexed citations
10.
Shimoda, M., et al.. (1996). Contribution of æ1‐acid glycoprotein to plasma protein binding of some basic antimicrobials in pigs. Journal of Veterinary Pharmacology and Therapeutics. 19(3). 176–183. 16 indexed citations
11.
Shin, Ho‐Chul, et al.. (1993). Identification of 10-formyltetrahydrofolate, tetrahydrofolate and 5-methyltetrahydrofolate as major reduced folate derivatives in rat bile. Journal of Chromatography B Biomedical Sciences and Applications. 620(1). 39–46. 15 indexed citations
13.
Vree, T. B., et al.. (1990). High-performance liquid chromatography of sulphadimethoxine and its N1-glucuronide, N4-acetyl and N4-acetyl-N1-glucuronide metabolites in human plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 526(1). 119–128. 31 indexed citations
14.
Vree, T. B., et al.. (1990). Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man. Pharmacy World & Science. 12(2). 51–59. 31 indexed citations
15.
Vree, T. B., et al.. (1990). O‐dealkylation and acetylation of sulphamethomidine by the turtlePseudemys scripta elegans. Veterinary Quarterly. 12(1). 60–63. 3 indexed citations
16.
Vree, T. B., et al.. (1989). Oxidation and O‐dealkylation of sulphamonomethoxine by the turtlePseudemys scripta elegans. Veterinary Quarterly. 11(3). 186–190. 6 indexed citations
17.
Vree, T. B., et al.. (1989). o‐Dealkylation and acetylation of sulfamethomidine by the snail Cepaea hortensis. Journal of Veterinary Pharmacology and Therapeutics. 12(3). 344–347. 4 indexed citations
18.
Shimoda, M., et al.. (1989). Effect of albumin distribution. Pharmacy World & Science. 11(3). 87–91. 5 indexed citations
19.
Vree, T. B., et al.. (1989). N‐oxidation, O‐demethylation, and excretion of trimethoprim by the turtlePseudemys scripta elegans. Veterinary Quarterly. 11(2). 125–128. 6 indexed citations
20.
Vree, T. B., et al.. (1989). O‐demethylation and N4‐acetylation of sulphadimethoxine by the turtlePseudemys scripta elegans. Veterinary Quarterly. 11(3). 138–143. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026